Does GLIMEPIRIDE Cause Hyperammonaemic encephalopathy? 10 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Hyperammonaemic encephalopathy have been filed in association with GLIMEPIRIDE (Glimepiride). This represents 0.2% of all adverse event reports for GLIMEPIRIDE.
10
Reports of Hyperammonaemic encephalopathy with GLIMEPIRIDE
0.2%
of all GLIMEPIRIDE reports
0
Deaths
10
Hospitalizations
How Dangerous Is Hyperammonaemic encephalopathy From GLIMEPIRIDE?
Of the 10 reports, 10 (100.0%) required hospitalization.
Is Hyperammonaemic encephalopathy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GLIMEPIRIDE. However, 10 reports have been filed with the FAERS database.
What Other Side Effects Does GLIMEPIRIDE Cause?
Hypoglycaemia (1,403)
Blood glucose increased (446)
Acute kidney injury (339)
Drug ineffective (339)
Diarrhoea (257)
Blood glucose decreased (232)
Lactic acidosis (219)
Glycosylated haemoglobin increased (214)
Diabetes mellitus inadequate control (213)
Hypoglycaemic coma (187)
What Other Drugs Cause Hyperammonaemic encephalopathy?
VALPROIC ACID (455)
FLUOROURACIL (156)
VALPROATE (120)
DIVALPROEX (119)
OXALIPLATIN (107)
TOPIRAMATE (101)
RISPERIDONE (96)
QUETIAPINE (91)
LEVETIRACETAM (71)
LEUCOVORIN (62)
Which GLIMEPIRIDE Alternatives Have Lower Hyperammonaemic encephalopathy Risk?
GLIMEPIRIDE vs GLIMEPIRIDE\ROSIGLITAZONE
GLIMEPIRIDE vs GLIPIZIDE
GLIMEPIRIDE vs GLIVEC
GLIMEPIRIDE vs GLOFITAMAB
GLIMEPIRIDE vs GLOFITAMAB-GXBM